Actelion 9-month Core EPS CHF 4.77, An Increase Of 42% At CER
Sartorius Stedim Biotec Q3 Sales Revenue EUR 170.1 Mln Vs EUR 144 Mln Last Year
AkzoNobel Q3 Revenue EUR 3.69 Bln, 3% Lower Than Last Year
Total Confirms Death Of Chairman And CEO Christophe De Margerie
Swiss biopharmaceutical company Actelion Ltd (ALIOF.PK) reported Tuesday that its net income for the first nine months climbed 86 percent to 566 million Swiss francs from last year's 304 million francs. Earnings per share grew 84 percent to 4.87 francs from 2.65 francs last year.
Core net income,...
Japan Aug All Industry Activity Index Falls 0.1% On Month, Consensus -0.4%
China Fixed Asset Investment +16.1% On Year In September